111 related articles for article (PubMed ID: 15342380)
21. Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.
Yaqinuddin A; Abbas F; Naqvi SZ; Bashir MU; Qazi R; Qureshi SA
Biosci Rep; 2008 Dec; 28(6):319-26. PubMed ID: 18666890
[TBL] [Abstract][Full Text] [Related]
22. RIL, a LIM gene on 5q31, is silenced by methylation in cancer and sensitizes cancer cells to apoptosis.
Boumber YA; Kondo Y; Chen X; Shen L; Gharibyan V; Konishi K; Estey E; Kantarjian H; Garcia-Manero G; Issa JP
Cancer Res; 2007 Mar; 67(5):1997-2005. PubMed ID: 17332327
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
Campo Dell'Orto M; Banelli B; Giarin E; Accordi B; Trentin L; Romani M; te Kronnie G; Basso G
Oncol Rep; 2007 Aug; 18(2):417-23. PubMed ID: 17611665
[TBL] [Abstract][Full Text] [Related]
24. A microarray model system identifies potential new target genes of the proto-oncogene HOX11.
Hoffmann K; Dixon DN; Greene WK; Ford J; Taplin R; Kees UR
Genes Chromosomes Cancer; 2004 Dec; 41(4):309-20. PubMed ID: 15384172
[TBL] [Abstract][Full Text] [Related]
25. Impaired recruitment of the histone methyltransferase DOT1L contributes to the incomplete reactivation of tumor suppressor genes upon DNA demethylation.
Jacinto FV; Ballestar E; Esteller M
Oncogene; 2009 Nov; 28(47):4212-24. PubMed ID: 19734945
[TBL] [Abstract][Full Text] [Related]
26. Patterned CpG methylation of silenced B cell gene promoters in classical Hodgkin lymphoma-derived and primary effusion lymphoma cell lines.
Doerr JR; Malone CS; Fike FM; Gordon MS; Soghomonian SV; Thomas RK; Tao Q; Murray PG; Diehl V; Teitell MA; Wall R
J Mol Biol; 2005 Jul; 350(4):631-40. PubMed ID: 15967459
[TBL] [Abstract][Full Text] [Related]
27. Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway.
McCabe MT; Davis JN; Day ML
Cancer Res; 2005 May; 65(9):3624-32. PubMed ID: 15867357
[TBL] [Abstract][Full Text] [Related]
28. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.
Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS
Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944
[TBL] [Abstract][Full Text] [Related]
29. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
[TBL] [Abstract][Full Text] [Related]
30. Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability.
Pise-Masison CA; Radonovich M; Dohoney K; Morris JC; O'Mahony D; Lee MJ; Trepel J; Waldmann TA; Janik JE; Brady JN
Blood; 2009 Apr; 113(17):4016-26. PubMed ID: 19131553
[TBL] [Abstract][Full Text] [Related]
31. Molecular characterization of chronic-type adult T-cell leukemia/lymphoma.
Yoshida N; Karube K; Utsunomiya A; Tsukasaki K; Imaizumi Y; Taira N; Uike N; Umino A; Arita K; Suguro M; Tsuzuki S; Kinoshita T; Ohshima K; Seto M
Cancer Res; 2014 Nov; 74(21):6129-38. PubMed ID: 25320005
[TBL] [Abstract][Full Text] [Related]
32. Identification of genes associated with the progression of adult T cell leukemia (ATL).
Kohno T; Moriuchi R; Katamine S; Yamada Y; Tomonaga M; Matsuyama T
Jpn J Cancer Res; 2000 Nov; 91(11):1103-10. PubMed ID: 11092974
[TBL] [Abstract][Full Text] [Related]
33. Phenotypic and functional relationship between adult T-cell leukemia cells and regulatory T cells.
Matsubara Y; Hori T; Morita R; Sakaguchi S; Uchiyama T
Leukemia; 2005 Mar; 19(3):482-3. PubMed ID: 15674359
[No Abstract] [Full Text] [Related]
34. [Comparative analysis of 2 methods of DNA extraction].
Sánchez García I; Martín Seisdedos C; Pérez Grande R; Corral de la Calle J; Rodríguez Arias C; González-Sarmiento R
Sangre (Barc); 1990 Oct; 35(5):405-7. PubMed ID: 2291150
[TBL] [Abstract][Full Text] [Related]
35. DNA methylation analysis of the EGR3 gene in patients of schizophrenia.
Hu TM; Hsu SH; Tsai SM; Cheng MC
Psychiatry Res; 2017 May; 251():115-117. PubMed ID: 28199908
[TBL] [Abstract][Full Text] [Related]
36. Identification of activity-induced Egr3-dependent genes reveals genes associated with DNA damage response and schizophrenia.
Marballi KK; Alganem K; Brunwasser SJ; Barkatullah A; Meyers KT; Campbell JM; Ozols AB; Mccullumsmith RE; Gallitano AL
Transl Psychiatry; 2022 Aug; 12(1):320. PubMed ID: 35941129
[TBL] [Abstract][Full Text] [Related]
37. Cancer stem cells: a target for overcoming therapeutic resistance and relapse.
Zhang S; Yang R; Ouyang Y; Shen Y; Hu L; Xu C
Cancer Biol Med; 2023 Dec; 20(12):985-1020. PubMed ID: 38164743
[TBL] [Abstract][Full Text] [Related]
38. Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia.
Noura M; Matsuo H; Yasuda T; Tsuzuki S; Kiyoi H; Hayakawa F
Oncogene; 2024 Feb; 43(6):447-456. PubMed ID: 38102337
[TBL] [Abstract][Full Text] [Related]
39. Dual targeting of aberrant DNA and histone methylation synergistically suppresses tumor cell growth in ATL.
Kurahashi Y; Watanabe T; Yamamoto Y; Ureshino H; Kamachi K; Yoshida-Sakai N; Fukuda-Kurahashi Y; Yamashita S; Hattori N; Nakamura H; Kawaguchi A; Ushijima T; Sueoka E; Kimura S
Blood Adv; 2023 Apr; 7(8):1545-1559. PubMed ID: 36516085
[TBL] [Abstract][Full Text] [Related]
40. Methylation Profiling of Specific Genes in Ependymomas.
Kanit N; Yalcin P; Erbayraktar S; Ozer E
Turk Patoloji Derg; 2022; 38(3):213-218. PubMed ID: 34854470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
